Cargando…

An Improvement of Survival Stratification in Glioblastoma Patients via Combining Subregional Radiomics Signatures

PURPOSE: To investigate whether combining multiple radiomics signatures derived from the subregions of glioblastoma (GBM) can improve survival prediction of patients with GBM. METHODS: In total, 129 patients were included in this study and split into training (n = 99) and test (n = 30) cohorts. Radi...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Yang, Han, Yu, Hu, Xintao, Wang, Wen, Cui, Guangbin, Guo, Lei, Zhang, Xin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8161502/
https://www.ncbi.nlm.nih.gov/pubmed/34054424
http://dx.doi.org/10.3389/fnins.2021.683452
_version_ 1783700525495091200
author Yang, Yang
Han, Yu
Hu, Xintao
Wang, Wen
Cui, Guangbin
Guo, Lei
Zhang, Xin
author_facet Yang, Yang
Han, Yu
Hu, Xintao
Wang, Wen
Cui, Guangbin
Guo, Lei
Zhang, Xin
author_sort Yang, Yang
collection PubMed
description PURPOSE: To investigate whether combining multiple radiomics signatures derived from the subregions of glioblastoma (GBM) can improve survival prediction of patients with GBM. METHODS: In total, 129 patients were included in this study and split into training (n = 99) and test (n = 30) cohorts. Radiomics features were extracted from each tumor region then radiomics scores were obtained separately using least absolute shrinkage and selection operator (LASSO) COX regression. A clinical nomogram was also constructed using various clinical risk factors. Radiomics nomograms were constructed by combing a single radiomics signature from the whole tumor region with clinical risk factors or combining three radiomics signatures from three tumor subregions with clinical risk factors. The performance of these models was assessed by the discrimination, calibration and clinical usefulness metrics, and was compared with that of the clinical nomogram. RESULTS: Incorporating the three radiomics signatures, i.e., Radscores for ET, NET, and ED, into the radiomics-based nomogram improved the performance in estimating survival (C-index: training/test cohort: 0.717/0.655) compared with that of the clinical nomogram (C-index: training/test cohort: 0.633/0.560) and that of the radiomics nomogram based on single region radiomics signatures (C-index: training/test cohort: 0.656/0.535). CONCLUSION: The multiregional radiomics nomogram exhibited a favorable survival stratification accuracy.
format Online
Article
Text
id pubmed-8161502
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-81615022021-05-29 An Improvement of Survival Stratification in Glioblastoma Patients via Combining Subregional Radiomics Signatures Yang, Yang Han, Yu Hu, Xintao Wang, Wen Cui, Guangbin Guo, Lei Zhang, Xin Front Neurosci Neuroscience PURPOSE: To investigate whether combining multiple radiomics signatures derived from the subregions of glioblastoma (GBM) can improve survival prediction of patients with GBM. METHODS: In total, 129 patients were included in this study and split into training (n = 99) and test (n = 30) cohorts. Radiomics features were extracted from each tumor region then radiomics scores were obtained separately using least absolute shrinkage and selection operator (LASSO) COX regression. A clinical nomogram was also constructed using various clinical risk factors. Radiomics nomograms were constructed by combing a single radiomics signature from the whole tumor region with clinical risk factors or combining three radiomics signatures from three tumor subregions with clinical risk factors. The performance of these models was assessed by the discrimination, calibration and clinical usefulness metrics, and was compared with that of the clinical nomogram. RESULTS: Incorporating the three radiomics signatures, i.e., Radscores for ET, NET, and ED, into the radiomics-based nomogram improved the performance in estimating survival (C-index: training/test cohort: 0.717/0.655) compared with that of the clinical nomogram (C-index: training/test cohort: 0.633/0.560) and that of the radiomics nomogram based on single region radiomics signatures (C-index: training/test cohort: 0.656/0.535). CONCLUSION: The multiregional radiomics nomogram exhibited a favorable survival stratification accuracy. Frontiers Media S.A. 2021-05-13 /pmc/articles/PMC8161502/ /pubmed/34054424 http://dx.doi.org/10.3389/fnins.2021.683452 Text en Copyright © 2021 Yang, Han, Hu, Wang, Cui, Guo and Zhang. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Neuroscience
Yang, Yang
Han, Yu
Hu, Xintao
Wang, Wen
Cui, Guangbin
Guo, Lei
Zhang, Xin
An Improvement of Survival Stratification in Glioblastoma Patients via Combining Subregional Radiomics Signatures
title An Improvement of Survival Stratification in Glioblastoma Patients via Combining Subregional Radiomics Signatures
title_full An Improvement of Survival Stratification in Glioblastoma Patients via Combining Subregional Radiomics Signatures
title_fullStr An Improvement of Survival Stratification in Glioblastoma Patients via Combining Subregional Radiomics Signatures
title_full_unstemmed An Improvement of Survival Stratification in Glioblastoma Patients via Combining Subregional Radiomics Signatures
title_short An Improvement of Survival Stratification in Glioblastoma Patients via Combining Subregional Radiomics Signatures
title_sort improvement of survival stratification in glioblastoma patients via combining subregional radiomics signatures
topic Neuroscience
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8161502/
https://www.ncbi.nlm.nih.gov/pubmed/34054424
http://dx.doi.org/10.3389/fnins.2021.683452
work_keys_str_mv AT yangyang animprovementofsurvivalstratificationinglioblastomapatientsviacombiningsubregionalradiomicssignatures
AT hanyu animprovementofsurvivalstratificationinglioblastomapatientsviacombiningsubregionalradiomicssignatures
AT huxintao animprovementofsurvivalstratificationinglioblastomapatientsviacombiningsubregionalradiomicssignatures
AT wangwen animprovementofsurvivalstratificationinglioblastomapatientsviacombiningsubregionalradiomicssignatures
AT cuiguangbin animprovementofsurvivalstratificationinglioblastomapatientsviacombiningsubregionalradiomicssignatures
AT guolei animprovementofsurvivalstratificationinglioblastomapatientsviacombiningsubregionalradiomicssignatures
AT zhangxin animprovementofsurvivalstratificationinglioblastomapatientsviacombiningsubregionalradiomicssignatures
AT yangyang improvementofsurvivalstratificationinglioblastomapatientsviacombiningsubregionalradiomicssignatures
AT hanyu improvementofsurvivalstratificationinglioblastomapatientsviacombiningsubregionalradiomicssignatures
AT huxintao improvementofsurvivalstratificationinglioblastomapatientsviacombiningsubregionalradiomicssignatures
AT wangwen improvementofsurvivalstratificationinglioblastomapatientsviacombiningsubregionalradiomicssignatures
AT cuiguangbin improvementofsurvivalstratificationinglioblastomapatientsviacombiningsubregionalradiomicssignatures
AT guolei improvementofsurvivalstratificationinglioblastomapatientsviacombiningsubregionalradiomicssignatures
AT zhangxin improvementofsurvivalstratificationinglioblastomapatientsviacombiningsubregionalradiomicssignatures